Fred Grossman - Jul 17, 2023 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Medical Officer
Signature
/s/ David Snyder, Attorney-in-Fact
Stock symbol
COYA
Transactions as of
Jul 17, 2023
Transactions value $
$0
Form type
4
Date filed
7/19/2023, 09:05 PM
Next filing
Feb 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award +74.1K 74.1K Jul 17, 2023 Common Stock, par value $0.0001 per share 74.1K $4.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continuous service, 24,689 of the shares subject to the option will vest on July 17, 2024, and the remaining shares will vest in equal monthly installments over a period of 24 months commencing on August 17, 2024.